Journal
AUTOIMMUNITY
Volume 41, Issue 1, Pages 55-65Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/08916930701619490
Keywords
autoantibodies; central nervous system; voltage-gated potassium channels; voltage-gated calcium channels; glutamic acid decarboxylase; aquaporin-4
Categories
Ask authors/readers for more resources
Autoimmunity has been demonstrated in a diverse range of peripheral neurological disorders, such as myasthenia gravis and acquired neuromyotonia. Serum antibodies found in these conditions are directed against ion channels and receptors situated on the cell surface and have been shown to produce pathogenic effects. The symptoms of these peripheral disorders have been transferred to animals by passive or active immunisation and, in humans, treated successfully with immunomodulatory therapy. Recently, a number of central nervous system disorders (CNS), such as limbic encephalitis, certain forms of epilepsy, neuromyelitis optica and cerebellar ataxia, have been hypothesised to associate with specific serum autoantibodies. In this article we consider this rapidly expanding field of CNS disorders, discuss evidence for their proposed autoimmune aetiology and review whether the antibodies detected have been shown to be pathogenic or if they are secondary to preceding neuronal damage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available